Eric Schmidt on joining Cantor Fitzgerald and his thoughts on the year ahead

blonca9
Jan 22, 2024
1 min read

Updated: Jan 24, 2024

Cantor Fitzgerald biotech analyst Eric Schmidt talks about themes he thinks will work in 2024, tracking important sickle cell and Alzheimer's launches, TCR programs, and more.

Recent Posts

See All

Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

Discussing hot button issues for biotech, and how they do or don't affect the mechanics of M&A, with one of the most experienced bankers in healthcare, Jefferies' Philip Ross

William Blair biotech analyst Andy Hsieh takes stock of the obesity space after attending the 2025 American Diabetes Association's (ADA's) 85th Scientific Sessions in Chicago

Eric Schmidt on joining Cantor Fitzgerald and his thoughts on the year ahead

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight